Compare RSKD & PRME Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | RSKD | PRME |
|---|---|---|
| Founded | 2012 | 2019 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | EDP Services | Medicinal Chemicals and Botanical Products |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 661.3M | 666.1M |
| IPO Year | 2021 | 2022 |
| Metric | RSKD | PRME |
|---|---|---|
| Price | $4.05 | $3.36 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 7 | 6 |
| Target Price | $5.96 | ★ $7.56 |
| AVG Volume (30 Days) | 728.0K | ★ 2.2M |
| Earning Date | 05-13-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 18.18 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $4,632,000.00 |
| Revenue This Year | $12.10 | N/A |
| Revenue Next Year | $10.19 | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 55.28 |
| 52 Week Low | $3.70 | $1.11 |
| 52 Week High | $5.68 | $6.94 |
| Indicator | RSKD | PRME |
|---|---|---|
| Relative Strength Index (RSI) | 44.06 | 43.05 |
| Support Level | $3.70 | $3.19 |
| Resistance Level | $4.91 | $3.94 |
| Average True Range (ATR) | 0.14 | 0.25 |
| MACD | 0.00 | -0.03 |
| Stochastic Oscillator | 49.29 | 41.21 |
Riskified Ltd has built a next-generation eCommerce risk management platform that allows online merchants to create trusted relationships with their consumers. It generates revenue by granting merchants access to its eCommerce risk management platform and reviewing and approving eCommerce transactions for legitimacy. Its merchants include some of the ecommerce brands including Wayfair, Lastminute.com, SHEIN, and Macy's. Its merchants operate in a variety of verticals, including Payments, Money Transfer & Crypto, Tickets & Travel, Electronics, Home, Fashion & Luxury Goods, General Retail and Food. The company derived maximum revenue from Israel.
Prime Medicine Inc is a biotechnology company committed to delivering genetic therapies to address diseases by deploying gene editing technology, Prime Editing. The Prime Editing technology is a next-generation technology that can search and replace to restore normal genetic function in the genome and can treat a wide spectrum of diseases with high unmet medical needs and efficient and broad gene editing technology.